Renaissance Technologies’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Renaissance Technologies’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-310,400	Closed	-$109K	–	3728
2018 Q2	$109K	Buy	310,400 +92,700	+43%	+$76K	﹤0.01%	3141
2018 Q1	$327K	Buy	217,700 +173,600	+394%	+$303K	﹤0.01%	3046
2017 Q4	$63K	Buy	+44,100	New	+$72.4K	﹤0.01%	3249
2016 Q3	–	Sell	-538,301	Closed	-$1.78M	–	3684
2016 Q2	$1.78M	Sell	538,301 -72,518	-12%	-$274K	﹤0.01%	2259
2016 Q1	$2.17M	Buy	+610,819	New	+$3.15M	﹤0.01%	2173

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies's ARLZ Position: Q3 2018 in Review

Renaissance Technologies sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 310,400 shares — an estimated $109K sold.

Renaissance Technologies first reported a position in ARLZ in Q1 2016 and held it in 5 quarters. The position peaked at $2.17M in Q1 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Renaissance Technologies reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Renaissance Technologies sold 310,400 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $109K.
Renaissance Technologies first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 5 quarters.
Renaissance Technologies's Aralez Pharmaceuticals Inc. position peaked at $2.17M in Q1 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.